1211515-16-0

Basic information

• Product Name: 2-chloro-5-fluoro-4-Methoxypyridine
• Synonyms: 2-chloro-5-fluoro-4-Methoxypyridine
• CAS NO: 1211515-16-0
• Molecular Formula: C₆H₅ClFNO
• Molecular Weight: 161.5614032
• Mol File: 1211515-16-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-chloro-5-fluoro-4-Methoxypyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-5-fluoro-4-Methoxypyridine(1211515-16-0)
• EPA Substance Registry System: 2-chloro-5-fluoro-4-Methoxypyridine(1211515-16-0)

Safety Data

• Hazardous Substances Data: 1211515-16-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-chloro-5-fluoro-4-Methoxypyridine is used as an intermediate for the synthesis of various pharmaceutical compounds. Its reactivity and selectivity in organic reactions make it a valuable component in the development of new drugs and materials.
Used in Agrochemical Industry:
2-chloro-5-fluoro-4-Methoxypyridine is used as a building block in the production of agrochemicals. Its versatility in chemical reactions allows for the synthesis of a wide range of agrochemical compounds.
Used in Specialty Chemicals Industry:
2-chloro-5-fluoro-4-Methoxypyridine is used as a key intermediate in the synthesis of specialty chemicals. Its functional groups enable it to participate in various chemical reactions, making it a valuable component in the development of diverse chemical compounds.
Used in Research and Development:
2-chloro-5-fluoro-4-Methoxypyridine is used as a research chemical in the development of new drugs and materials. Its unique properties and reactivity make it a promising candidate for further exploration and innovation in the field of chemistry.

Upstream product

• 74-88-4 methyl iodide 
• 1060805-03-9 3-fluoro-4-methoxypyridine 
• 31301-51-6 2-chloro-5-fluoropyridine 

Downstream Products

• 1369764-11-3 (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-N-(5-fluoro-4-methoxypyridin-2-yl)-2-(4-fluorophenyl)cyclopropanecarboxamide 
• 1369764-01-1 (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-N-(5-fluoro-4-methoxypyridin-2-yl)-2-(3-fluorophenyl)cyclopropanecarboxamide 
• 1369763-77-8 (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-N-(5-fluoro-4-methoxypyridin-2-yl)-2-phenylcyclopropanecarboxamide 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE

The present disclosure provides compounds useful for the inhibition of Delta-5 Desaturase ("D5D"). The compounds have a general Formula (I): wherein the variables of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a metabolic or cardiovascular disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).

PYRIDINE CARBONYL DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS

The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

NOVEL TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I): wherein R1, R2, R3, Q, U,W, Z, X and Y are as described herein, compositions including the compounds and methods of using the compounds. These compounds are HbsAg inhibitors and are useful as medicaments for the treatment or prophylaxis of HBV infection.

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

The present invention provides, in part, compounds of Formula (I) and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1 -mediated (or D1 -associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson's disease.